Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 4,843 | 4,847 | 4,949 | 5,262 | 719 |
| Accounts receivable | 3,387 | -4,820 | 13,857 | -18,447 | -457 |
| Accounts payable and accrued liabilities | 6,877 | -6,594 | 1,582 | 10,567 | 5,362 |
| Other Working Capital | 5,781 | -10,761 | 19,431 | -13,904 | 2,119 |
| Other Operating Activity | -5,045 | -1,270 | -25,507 | 3,245 | -10,569 |
| Operating Cash Flow | $15,843 | $-18,598 | $14,312 | $-13,277 | $-2,826 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -299 | 105 | -177 |
| Purchase Of Investment | -196,866 | -121,260 | -144,287 | -122,774 | -114,042 |
| Sale Of Investment | 158,372 | 170,505 | 138,089 | 102,996 | 120,525 |
| Other Investing Activity | -128 | -12 | 240 | -28 | -11,914 |
| Investing Cash Flow | $-38,622 | $49,233 | $-6,257 | $-19,701 | $-5,608 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,223 | -2,778 | -6,543 | N/A | N/A |
| Common Stock Repurchased | -6,134 | -12,301 | N/A | N/A | N/A |
| Other Financing Activity | 1,084 | 28 | 966 | -2,332 | 1,140 |
| Financing Cash Flow | $-8,273 | $-15,051 | $-5,577 | $-2,332 | $1,140 |
| Beginning Cash Position | 64,459 | 48,875 | 46,397 | 81,707 | 89,001 |
| End Cash Position | 33,407 | 64,459 | 48,875 | 46,397 | 81,707 |
| Net Cash Flow | $-31,052 | $15,584 | $2,478 | $-35,310 | $-7,294 |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,843 | -18,598 | 14,312 | -13,277 | -2,826 |
| Capital Expenditure | -84 | -12 | -59 | N/A | -227 |
| Free Cash Flow | 15,759 | -18,610 | 14,253 | -13,277 | -3,053 |